Luca V. C. Valenti

University Name

Italy

Has grant

This profile is automatically generated from trusted academic sources.

Google Scholar

ORCID

How do I reach out?

Meet Kite AI

Contact this professor

ORCID

Google Scholar

Academic Page

Research Interests

Internal Medicine

30%

Cardiology

30%

Fatty Liver

70%

Liver Transplantation

50%

Hepatocellular Carcinoma

40%

Cardiometabolic Health

40%

Metabolic Syndrome

30%

Ask ApplyKite AI

Start chatting

How can you help me contact this professor?

What are this professor's research interests?

How should I write an email to this professor?

Recent Grants

Grant: Close

5) Understanding Gene ENvironment Interaction in ALcohol-related hepatocellular carcinoma (GENIAL)

Open Date: 2023-01-01

Close Date: 2026-01-01

Grant: Close

Developing a model of care for risk stratification and management of diabetic patients with non-alcoholic fatty liver disease (NAFLD):

Open Date: 2022-01-01

Close Date: 2024-01-01

Grant: Close

FOGS 2021

Open Date: 2021-07-01

Close Date: 2023-07-01

Grant: Close

Neuronal microscopy for cell behavioural examination and manipulation

Open Date: 2021-01-01

Close Date: 2024-12-31

Grant: Close

COVID-19 Biobanking

Open Date: 2020-04-01

Close Date: 2021-05-01

Articles11

The first <scp>MASH</scp> drug therapy on the horizon: Current perspectives of resmetirom

Article Link

Year:

2024

A multi-society Delphi consensus statement on new fatty liver disease nomenclature

Article Link

Year:

2023

A global research priority agenda to advance public health responses to fatty liver disease

Article Link

Year:

2023

A multi-society Delphi consensus statement on new fatty liver disease nomenclature

Article Link

Year:

2023

A global action agenda for turning the tide on fatty liver disease.

Article Link

Year:

2023

Rationale and design of the CV-PREVITAL study: an Italian multiple cohort randomised controlled trial investigating innovative digital strategies in primary cardiovascular prevention

Article Link

Year:

2023

Usefulness of <i>PNPLA3</i> variant for predicting hepatic events in steatotic liver disease: a matter of ethnicity or baseline risk?

Article Link

Year:

2023

Editorial: Unveiling new horizons for liver steatosis genetic variants beyond hepatocellular carcinoma diagnosis ‐ exploring the potential of HSD17B13 inhibition

Article Link

Year:

2023

The genetics of portal hypertension: Recent developments and the road ahead

Article Link

Year:

2023

Comparison of the severity of metabolic, liver and cardiovascular damage in NAFLD patients attending the hepatology clinic over the last three decades.

Article Link

Year:

2023

A multi-society Delphi consensus statement on new fatty liver disease nomenclature.

Article Link

Year:

2023

Collaborators23

Luca Miele

Catholic University of the Sacred Heart

ITALY

Alessio Aghemo

ITALY

Davide Fortin

Barcelona Institute for Global Health

SPAIN

François R. Jornayvaz

University Hospital of Geneva

SWITZERLAND

Licia Iacoviello

Professore ordinario

Università degli Studi di Roma La Sapienza

ITALY

Aleksander Krag

Odense University Hospital

DENMARK

Saleh Alqahtani

Johns Hopkins University

UNITED STATES

Damiano Baldassarre

Associate Professor

Università degli Studi di Roma Tor Vergata Facoltà di Medicina e Chirurgia

ITALY

Philip Newsome

University of Birmingham

UNITED KINGDOM

Maja Thiele

Odense University Hospital

DENMARK

Maria Paula Macedo

Full Professor

PORTUGAL

Utpal Pajvani

UNITED STATES

Giuseppe Ferrante

Assistant Professor

Humanitas University

ITALY

Quentin M. Anstee

Newcastle University

UNITED KINGDOM

Laura Comini

Istituti Clinici Scientifici Maugeri SpA IRCCS Lumezzane

ITALY

helen jarvis

GP Clinical Lecturer

Newcastle University

UNITED KINGDOM

Juan Pablo Arab

Western University

CANADA

Maria Luisa Ojeda Fernández

Istituto di Ricerche Farmacologiche Mario Negri

ITALY

Gyorgy Baffy

Associate Professor

Harvard Medical School

UNITED STATES

Nicolas Goossens

Chargé de Cours, Lecturer

University of Geneva

SWITZERLAND

Stefano Romeo

SWEDEN

Marcela Villota-Rivas

Barcelona Institute for Global Health

SPAIN

Umberto Vespasiani‐Gentilucci

ITALY

How do I reach out?

Meet Kite AI